ArticleTargeted oncology2023

A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer.

Jose De La Cerda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.